Login
Home / 6917.TWO : TWO
Follow Compare
AI Analysis Fundamentals Valuation Video Analysis Similar
Quarterly Quarterly (TTM) Annually

AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Andros Pharmaceuticals Co.,Ltd

TWD 36.15 +$11.85 (+48.77%)
TWO · 16 Sep 2026 06:14 UTC
Previous Close
TWD 35.8
Day Range
TWD 35.05TWD 36.15
Year Range
TWD 18.35TWD 45.95
Market Cap
1.98B
AVG Volume
352.71K
Trailing/Forward PE
-57.38/-
PEG ratio
-0.57
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Taipei ExchangeTW
Revenue (TWD)
02M4M6M25 Q426 Q2
Net Income (TWD)
-30M-20M-10M025 Q426 Q2
Operating Income (TWD)
-40M-30M-20M-10M025 Q426 Q2
EBITDA (TWD)
-40M-30M-20M-10M025 Q426 Q2
Cash Flows (TWD)
-30M-20M-10M010M25 Q426 Q2
EPS (TWD)
-0.6-0.4-0.2-025 Q426 Q2
Expenses (TWD)
010M20M30M40MR&DSG&ACapex25 Q426 Q2
Cash & Debt (TWD)
0200M400M600MCashShort Term Debt22 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Debt ratios
02.557.51022 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Margins
-40%-30%-20%-10%0%25 Q426 Q2
Return on Capital
-6%-4%-2%0%25 Q426 Q2
Shares Outstanding
020M40M60M25 Q426 Q2
Book Value Per Share (TWD)
05101525 Q426 Q2
Total Assets (TWD)
0200M400M600M22 Q423 Q223 Q424 Q224 Q425 Q225 Q426 Q2
Price to Book
22.533.5med 2.89Apr 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26
Andros Pharmaceuticals Co.,Ltd
6917.TWO
Stockpicker

Video analysis: 6917.TWO

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.